Abstract

BackgroundThe production of integral membrane spanning proteins (IMP's) constitutes a bottleneck in pharmaceutical development. It was long considered that the state-of-the-art was to produce the proteins as inclusion bodies using a powerful induction system. However, the quality of the protein was compromised and the production of a soluble protein that is incorporated into the membrane from which it is extracted is now considered to be a better method. Earlier research has indicated that a slower rate of protein synthesis might overcome the tendency to form inclusion bodies. We here suggest the use of a set of E. coli mutants characterized by a slower rate of growth and protein synthesis as a tool for increasing the amount of soluble protein in high- throughput protein production processes.ResultsA set of five IMP's was chosen which were expressed in three mutants and the corresponding WT cell (control). The mutations led to three different substrate uptake rates, two of which were considerably slower than that of the wild type. Using the mutants, we were able to express three out of the five membrane proteins. Most successful was the mutant growing at 50% of the wild type growth rate. A further effect of a low growth rate is a low acetic acid formation, and we believe that this is a possible reason for the better production. This hypothesis was further supported by expression from the BL21(DE3) strain, using the same plasmid. This strain grows at a high growth rate but nevertheless yields only small amounts of acetic acid. This strain was also able to express three out of the five IMP's, although at lower quantities.ConclusionsThe use of mutants that reduce the specific substrate uptake rate seems to be a versatile tool for overcoming some of the difficulties in the production of integral membrane spanning proteins. A set of strains with mutations in the glucose uptake system and with a lower acetic acid formation were able to produce three out of five membrane proteins that it was not possible to produce with the corresponding wild type.

Highlights

  • The production of integral membrane spanning proteins (IMP’s) constitutes a bottleneck in pharmaceutical development

  • The aim of this study was to understand whether a reduction in the growth rate/substrate uptake rate would lead to a greater success in the production of soluble integral membrane spanning proteins in E. coli

  • The mutants are characterized by their inability to take up glucose through the deleted permeases: (i) a defective enzyme IIABMan, which unspecifically controls the uptake of mannose and allows glucose passage, (ii) a defective enzyme IIBCGlc, specific for glucose uptake, and (iii) the double mutant, in which glucose is taken up by symport

Read more

Summary

Introduction

The production of integral membrane spanning proteins (IMP’s) constitutes a bottleneck in pharmaceutical development. A common way to overcome expression difficulties is to lower the temperature, which is a parameter that can be used regardless of expression system and protein. The reason why this is efficient in a particular case is difficult to identify since the temperature affects a large number of cellular mechanisms as well as all the equilibrium constants. In membrane protein production, it has been clearly shown that when a strong induction system like the BL21(DE3) strain is used, it is the high and immediate rate of protein-specific mRNA accumulation, resulting from high level T7 RNA polymerase production, that has detrimental effects on the host cell and lowers the product yield [1,2,3]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call